{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T01:35:03Z","timestamp":1773797703299,"version":"3.50.1"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jsm.jsexmed.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>We sought to evaluate whether the administration of phenylephrine (PE) at concentrations higher than those described in guidelines resulted in any significant changes in vital signs or impacted outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>After receiving institutional review board approval, we retrospectively reviewed the charts of patients presenting to our emergency department between May 1, 2014, and August 15, 2016, using International Classification of Diseases, Ninth Edition and Internation Classification of Disease, Tenth Edition diagnosis codes for priapism. Treatment was reviewed, including corporal aspiration\/irrigation, injection of PE, and shunt procedures. Vital signs were compared before and after treatment with PE. Baseline variables were explored with categorical data analysis (chi-squared tests, t-tests, and Mann-Whitney nonparametric tests). Where feasible, linear regression was used to evaluate outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Outcome Measure<\/jats:title>\n                  <jats:p>Detumescence and changes in blood pressure and heart rate.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We identified 74 different patient encounters of acute priapism. The median age was 36.5 years (interquartile range [IQR]\u00a0= 27\u201347), and the median time to presentation was 5.4 hours (IQR\u00a0= 4.0\u20139.6). 62 percent of cases were due to drug-induced priapism. In 58 (74%) encounters, patients received PE. The median dose of PE given was 1000 \u03bcg (IQR 500\u20132,000). Univariate regression found no association between PE dose and change in patient heart rate or blood pressure. A statistically significant decrease in heart rate (HR) (\u22124.2\u00a0BPM), systolic blood pressure (BP) (\u22121.8 mm Hg), and diastolic BP (\u22125.4 mm Hg) was noted. Fifty-three of 58 (91%) patients receiving PE experienced detumescence at the bedside, 2 required shunting in operating room, and 3 refused treatment and left against medical advice. No adverse events occurred.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>We frequently treat patients with high doses of PE and seldom notice adverse effects, typically resulting in resolution of priapism without any additional procedures. Careful administration of high doses of intracavernosal PE in patients presenting with priapism does not appear to significantly affect heart rate or blood pressure and may help prevent further ischemic damage and achieve detumescence effectively and efficiently.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1016\/j.jsxm.2018.05.012","type":"journal-article","created":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T01:02:17Z","timestamp":1530147737000},"page":"990-996","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["The Hemodynamic Effects of Intracavernosal Phenylephrine for the Treatment of Ischemic Priapism"],"prefix":"10.1093","volume":"15","author":[{"given":"Ajaydeep S.","family":"Sidhu","sequence":"first","affiliation":[{"name":"Mount Sinai Medical Center , Miami Beach, FL , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George F.","family":"Wayne","sequence":"additional","affiliation":[{"name":"Mount Sinai Medical Center , Miami Beach, FL , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bu J.","family":"Kim","sequence":"additional","affiliation":[{"name":"Florida International University Herbert Wertheim College of Medicine , Miami, FL , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander G.S.","family":"Anderson","sequence":"additional","affiliation":[{"name":"University of Central Florida College of Medicine , Orlando, FL , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Billy H.","family":"Cordon","sequence":"additional","affiliation":[{"name":"Columbia Urology Division of Urology at Mount Sinai Medical Center , Miami Beach, FL , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge R.","family":"Caso","sequence":"additional","affiliation":[{"name":"Baptist Health South Florida , Miami, FL , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Scott","family":"Polackwich","sequence":"additional","affiliation":[{"name":"Columbia Urology Division of Urology at Mount Sinai Medical Center , Miami Beach, FL , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,7,1]]},"reference":[{"issue":"5","key":"2023012309502454800_bib1","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0090-4295(01)00941-4","article-title":"Incidence of priapism in the general population","volume":"57","author":"Eland","year":"2001","journal-title":"Urology"},{"issue":"1 Pt 2","key":"2023012309502454800_bib2","first-page":"476","article-title":"Priapism: pathogenesis, epidemiology, and management","volume":"7","author":"Broderick","year":"2010","journal-title":"J\u00a0Sex Med"},{"issue":"4 Pt 1","key":"2023012309502454800_bib3","first-page":"1318","article-title":"American Urological Association guideline on the management of priapism","volume":"170","author":"Montague","year":"2003","journal-title":"J\u00a0Urol"},{"issue":"4","key":"2023012309502454800_bib4","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.amjsurg.2010.03.017","article-title":"Priapism in the United States: the changing role of sickle cell disease","volume":"201","author":"Chrouser","year":"2011","journal-title":"Am J Surg"},{"issue":"9","key":"2023012309502454800_bib5","first-page":"2152","article-title":"Investigating the effects of high-dose phenylephrine in the management of prolonged ischaemic priapism","volume":"5","author":"Muneer","year":"2008","journal-title":"J\u00a0Sex Med"},{"issue":"5","key":"2023012309502454800_bib6","first-page":"918","article-title":"Management of ischemic priapism with high-dose intracavernosal phenylephrine: from bench to bedside","volume":"3","author":"Wen","year":"2006","journal-title":"J\u00a0Sex Med"},{"issue":"2","key":"2023012309502454800_bib7","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.eururo.2013.11.008","article-title":"European Association of Urology guidelines on priapism","volume":"65","author":"Salonia","year":"2014","journal-title":"Eur Urol"},{"issue":"4","key":"2023012309502454800_bib8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/BF02550631","article-title":"The usefulness of ethylephrine (Efortil-R) in the treatment of priapism and intraoperative penile erections","volume":"24","author":"Serrate","year":"1992","journal-title":"Int Urol Nephrol"},{"issue":"9\u201310","key":"2023012309502454800_bib9","first-page":"648","article-title":"Ambulatory treatment and prevention of priapism using alpha-agonists. Apropos of 172 cases","volume":"121","author":"Virag","year":"1997","journal-title":"Chirurgie"},{"issue":"4","key":"2023012309502454800_bib10","first-page":"476","article-title":"Emergency management of priapism in the United Kingdom: A survey of current practice","volume":"15","author":"Bullock","year":"2018","journal-title":"J\u00a0Sex Med"},{"issue":"4","key":"2023012309502454800_bib11","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ucl.2007.08.006","article-title":"Priapism: current principles and practice","volume":"34","author":"Burnett","year":"2007","journal-title":"Urol Clin North Am"},{"issue":"1","key":"2023012309502454800_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5152\/tud.2017.59458","article-title":"Ischaemic priapism: A clinical review","volume":"43","author":"Ridgley","year":"2017","journal-title":"Turk J Urol"},{"issue":"2","key":"2023012309502454800_bib13","first-page":"310","article-title":"The application of intracavernous injection of vasoactive medications for erection in men with spinal cord injury","volume":"138","author":"Bodner","year":"1987","journal-title":"J\u00a0Urol"},{"issue":"4","key":"2023012309502454800_bib14","first-page":"1025","article-title":"Subarachnoid hemorrhage as complication of phenylephrine injection for the treatment of ischemic priapism in a sickle cell disease patient","volume":"5","author":"Davila","year":"2008","journal-title":"J\u00a0Sex Med"},{"issue":"3","key":"2023012309502454800_bib15","first-page":"25","article-title":"A\u00a0case of acute coronary syndrome following intracavernosal phenylephrine injection for tamsulosin induced priapism","volume":"4","author":"Kariyanna","year":"2015","journal-title":"J\u00a0Appl Med Sci"},{"issue":"1","key":"2023012309502454800_bib16","first-page":"141","article-title":"Intracorporeal phenylephrine in the treatment of priapism","volume":"155","author":"Muruve","year":"1996","journal-title":"J\u00a0Urol"},{"issue":"6","key":"2023012309502454800_bib17","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/sj.ijir.3900539","article-title":"Intracavernosal adrenalin injection in priapism","volume":"12","author":"Keskin","year":"2000","journal-title":"Int J Impot Res"},{"issue":"11","key":"2023012309502454800_bib18","first-page":"1704","article-title":"Use of high-dose phenylephrine in the treatment of ischemic priapism: Five-year experience at a single institution","volume":"13","author":"Ridyard","year":"2016","journal-title":"J\u00a0Sex Med"},{"issue":"10","key":"2023012309502454800_bib19","first-page":"2418","article-title":"Nationwide emergency department visits for priapism in the United States","volume":"10","author":"Stein","year":"2013","journal-title":"J\u00a0Sex Med"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609518310038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609518310038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/15\/7\/990\/48589485\/jsm_15_7_990.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/15\/7\/990\/48589485\/jsm_15_7_990.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T10:28:21Z","timestamp":1674469701000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/15\/7\/990\/6980697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,1]]},"references-count":19,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018,7,1]]},"published-print":{"date-parts":[[2018,7,1]]}},"URL":"https:\/\/doi.org\/10.1016\/j.jsxm.2018.05.012","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2018,7]]},"published":{"date-parts":[[2018,7,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Hemodynamic Effects of Intracavernosal Phenylephrine for the Treatment of Ischemic Priapism","name":"articletitle","label":"Article Title"},{"value":"The Journal of Sexual Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsxm.2018.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}